Want to see FR:SIGHT full AI Analyst Report?
GenSight Biologics SA (SIGHT) Stock Forecast & Price Target
SIGHT Analyst Ratings
There are no analyst ratings in the last 3 months.
SIGHT Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Keay Nakae | Chardan Capital | EUR 0.08 | hold | 15.94%Upside | Reiterated | 07/15/26 | ||
| Justine Telliez | Kepler Capital | EUR 0.40 | hold | 479.71%Upside | Reiterated | 04/08/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Keay NakaeChardan Capital | HoldReiteratedEUR 0.08 | 07/15/26 | 15.94%Upside | ||
| Justine TelliezKepler Capital | HoldReiteratedEUR 0.40 | 04/08/26 | 479.71%Upside |
Best Analysts Covering GenSight Biologics SA
Copying Google Health Care EU's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of +5.10% per trade.
Copying Google Health Care EU's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -1.35% per trade.
Copying Google Health Care EU's trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -1.35% per trade.
SIGHT Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 1 | 0 | 0 |
In the current month, SIGHT has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SIGHT average Analyst price target in the past 3 months is ―.
SIGHT Financial Forecast
SIGHT Earnings Forecast
Next quarter’s earnings estimate for SIGHT is -EUR 0.05 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.05. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
SIGHT Sales Forecast
Next quarter’s sales forecast for SIGHT is -EUR 1.21M with a range of ― to ―. The previous quarter’s sales results were -EUR 1.21M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
